Etherna

Developer of mRNA-based immunotherapies for cancer and infectious diseases

placeNiel, Flanders, Belgium calendar_todayFounded 2013 groups80 employees language etherna.be

Registered entities

Social engagement

Social engagement: 14.2K social following, 6 posts in the last 12 months — around the industry typical range.

Investor mix

15 investors on record; lead investors include Life Sciences Partners, PMV, Array, Novalis LifeSciences.

Investor typeCountShare
Venture capital533%
Private equity213%
Accelerator & incubator17%
Bank & private debt17%
Other / undisclosed640%

Recent activity

1 Jul 2026
Partnership
Valero Therapeutics
28 May 2026
Event
BIO International Convention 2026
12 May 2026
Event
BIO Partnering for Oncology
Coming soon